glp 1 and dpp4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner GLP-1 receptor agonist versus DPP-4
Description
2024;150(Suppl_1):A4113997-A4113997
Introduce fiber incrementally to allow the digestive system to adjust, particularly given that GLP-1 medications already slow gastric emptying
GLP-1 also lowers glucagon secretion from pancreatic alpha cells, leading to reduced hepatic glucose production
Tests such as the Trio-Smart 3-Gas Breath Test can help identify whether SIBO, IMO, or ISO is present, supporting more informed clinical decisions
Metabolic health: GLP-1s were initially used to treat diabetes
